HPV-targeted adoptive T Cell therapy for advanced cervical cancer
Listen now
Description
Dr Hinrichs talks to ecancertv at ASCO 2014 about his work using immunotherapy to tackle cervical cancer. HPV-targeted tumour-infiltrating lymphocytes for the treatment of cervical cancer is a new field.
More Episodes
At ASCO 2014, Dr O'Day provides ecancertv with his expert opinion on the findings from a large phase I study of 411 patients with advanced melanoma which showed that the PD-1 targeting antibody MK-3475 yields long-term responses in a high percentage of patients.
Published 07/15/14
Published 07/15/14
ecancer's Prof McVie provides a roundup of the main points of discussion from ASCO 2014.
Published 07/11/14